Aperio Group, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$161,000
-10.6%
10,418
-15.5%
0.00%
-100.0%
Q3 2020$180,000
-26.2%
12,329
-4.2%
0.00%0.0%
Q2 2020$244,000
-6.5%
12,866
-5.3%
0.00%0.0%
Q1 2020$261,000
+26.1%
13,584
+25.8%
0.00%0.0%
Q4 2019$207,000
+762.5%
10,802
+174.4%
0.00%
Q2 2019$24,000
-91.3%
3,937
-46.7%
0.00%
-100.0%
Q4 2014$276,000
-61.3%
7,381
-63.9%
0.00%
-70.0%
Q3 2014$714,00020,4210.01%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders